Effect of intraperitoneal hyperthermic perfusion chemotherapy combined with radiofrequency hyperthermia on elderly patients with advanced ovarian cancer
10.3969/j.issn.1000-484X.2018.04.020
- VernacularTitle:腹腔热灌注化疗联合腹部射频热疗对老年晚期卵巢癌患者的疗效分析
- Author:
Ai-Hong WANG
1
;
Ju-Mei ZHAO
;
Juan DU
;
De-Fang FANG
;
Xin-Jian FANG
;
Ming-Quan WANG
Author Information
1. 延安大学医学院及延安市肿瘤防治研究重点实验室
- Keywords:
Hyperthermia;
Cytoreductive surgery;
Intraperitoneal hyperthermia;
Elderly;
Ovarian cancer
- From:
Chinese Journal of Immunology
2018;34(4):583-588
- CountryChina
- Language:Chinese
-
Abstract:
Objective:By observing the changes of hyperthermia on serum carbohydrate antigen 125(CA125),human epididymal protein 4(HE4),chitinase protein(YKL) and immune function index effects,to investigate its effect on cancerous ascites and its antitumor effect of cytoreductive surgery combined with intraperitoneal hyperthermic perfusion chemotherapy and in elderly patients with advanced ovarian cancer.Methods: A total of 72 elderly patients with advanced ovarian cancer were enrolled in the study.They were randomly divided into contrast treatment group and combined treatment group,36 cases in each group.The patients in contrast treatment group were treated with cytoreductive surgery combined with intraperitoneal hyperthermic perfusion chemotherapy.The combined treatment group was treated with partial radiofrequency hyperthermia on the basis of the treatment of the control group.The efficacy was evaluated after 2 courses.The changes of CA125,HE4 and YKL contents and T cell subsets were compared between the two groups before and after treatment,and the safety was evaluated.Results: There was no difference in the operation between the two groups.The total effective rate was 80.0% in combined treatment group,which was significantly better than 55.6% in contrast treatment group(χ2=5.175,P<0.01).The effective rate of ascites control was 80.6% in combined treatment group,which was significantly higher than that in contrast treatment group 52.4%(χ2=3.962,P<0.05).After treatment,the levels of CA125,HE4 and YKL in the two groups were significantly lower than those before treatment,and the decrease of the combined treatment group was more significant than contrast treatment group(P<0.05).After treatment,the levels of CD3+,CD4+,CD4+/CD8+in both groups were lower than those before treatment,CD8+was lower than that before treatment,and the improvement of the indexes in combined treatment group was more significant than contrast treatment group(P<0.05).There was no significant difference between the two groups in the adverse effects of bone marrow suppression,gastrointestinal reaction and liver and kidney dysfunction(P> 0.05).Conclusion: CRS combined with IPHC and hyperthermia can significantly improve the immunosuppression of ovarian cancer,reduce the level of CA125,HE4,YKL, improve clinical efficacy of elderly patients with advanced ovarian cancer.
